Transcatheter Aortic Valve Implantation (TAVI) Market Global Opportunities and Forecasts, 2014 – 2022
Allied Market Research added new research report on “Transcatheter Aortic Valve Implantation Market” includes Industry Size, Share, Trends, Growth, Demand, Supply, Market Development, Analysis and Forecast
Transcatheter Aortic Valve Implantation Market is expected to garner $5,962 billion by 2020, registering a CAGR of 16.5% during the forecast period 2016 – 2022. Transcatheter aortic valve implantation (TAVI), a minimally invasive procedure, is utilized to treat high-risk or inoperable aortic stenosis patients. This procedure involves implantation of specially designed transcatheter aortic valves that have the ability to regenerate the heart’s blood pumping function of the aortic valve. It is conducted through three approaches: transfemoral TAVI, transapical TAVI, and transaortic TAVI. Furthermore, the report provides market estimation on the basis of value as well as volume of TAVI devices.
Get Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/1675
Transfemoral implantation is the standardized TAVI procedure, in which an artificial valve is implanted through the femoral artery with minimal anesthesia. Hence, this segment accounted for the highest market share in 2015 and is expected to maintain its dominance during the forecast period. However, this procedure has some complications due to higher distance from insertion to the aortic valve, which has led to the emergence of transapical TAVI and transaortic TAVI procedures.
Send an enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1675
An increase in the percentage of the Mexican population, especially adults, prone to symptomatic aortic stenosis has been observed. As per the World Health Organization, deaths due to coronary heart diseases have reached to 76,043 or 14.72% of total deaths in 2014, and coronary heart disease and stroke ranked second and third in Mexico. Increase in incidence of aortic stenosis coupled with high-risk geriatric population boosts the growth of the Mexican TAVI market. In addition, medical tourism plays a vital role in market growth. Patients from developed countries such as the U.S., Canada, and Spain visit Mexico for heart-related treatments, owing to lower treatment cost and liberal regulatory framework in Mexico. The first TAVR procedure successfully completed in North America was performed in Mexico.
Browse Complete Report @ https://www.alliedmarketresearch.com/tavi-market
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.